Characterization of Prion Disease Associated with a Two-Octapeptide Repeat Insertion.


Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
08 09 2021
Historique:
received: 02 08 2021
revised: 31 08 2021
accepted: 04 09 2021
entrez: 28 9 2021
pubmed: 29 9 2021
medline: 12 2 2022
Statut: epublish

Résumé

Genetic prion disease accounts for 10-15% of prion disease. While insertion of four or more octapeptide repeats are clearly pathogenic, smaller repeat insertions have an unclear pathogenicity. The goal of this case series was to provide an insight into the characteristics of the 2-octapeptide repeat genetic variant and to provide insight into the risk for Creutzfeldt-Jakob disease in asymptomatic carriers. 2-octapeptide repeat insertion prion disease cases were collected from the National Prion Disease Pathology Surveillance Center (US), the National Prion Clinic (UK), and the National Creutzfeldt-Jakob Disease Registry (Australia). Three largescale population genetic databases were queried for the 2-octapeptide repeat insertion allele. Eight cases of 2-octapeptide repeat insertion were identified. The cases were indistinguishable from the sporadic Creutzfeldt-Jakob cases of the same molecular subtype. Western blot characterization of the prion protein in the absence of enzymatic digestion with proteinase K revealed that 2-octapeptide repeat insertion and sporadic Creutzfeldt-Jakob disease have distinct prion protein profiles. Interrogation of large-scale population datasets suggested the variant is of very low penetrance. The 2-octapeptide repeat insertion is at most a low-risk genetic variant. Predictive genetic testing for asymptomatic blood relatives is not likely to be justified given the low risk.

Identifiants

pubmed: 34578375
pii: v13091794
doi: 10.3390/v13091794
pmc: PMC8473248
pii:
doi:

Substances chimiques

Oligopeptides 0
Prion Proteins 0
Prions 0
Methionine AE28F7PNPL

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Medical Research Council
ID : MC_UU_00024/1
Pays : United Kingdom
Organisme : NIH HHS
ID : AG068359
Pays : United States
Organisme : Medical Research Council
ID : MC_UU_00024/6
Pays : United Kingdom
Organisme : CDC HHS
ID : 1NU38CK000480
Pays : United States
Organisme : NIA NIH HHS
ID : K99 AG068359
Pays : United States

Références

J Biol Chem. 2010 Apr 30;285(18):13874-84
pubmed: 20194495
Neurology. 2007 Aug 21;69(8):730-8
pubmed: 17709704
Annu Rev Neurosci. 2001;24:519-50
pubmed: 11283320
Ann Neurol. 1999 Aug;46(2):224-33
pubmed: 10443888
Neurology. 1993 Nov;43(11):2392-4
pubmed: 8232966
Handb Clin Neurol. 2018;148:441-464
pubmed: 29478593
Ann Neurol. 2017 Jan;81(1):79-92
pubmed: 27893164
Sci Transl Med. 2016 Jan 20;8(322):322ra9
pubmed: 26791950
Acta Neuropathol Commun. 2015 Jun 25;3:37
pubmed: 26108478
Mol Genet Genomic Med. 2020 Mar;8(3):e1134
pubmed: 31953922
Brain. 2006 Mar;129(Pt 3):676-85
pubmed: 16415305
Front Cell Neurosci. 2020 Jul 08;14:150
pubmed: 32733203
Ann Neurol. 1996 Jun;39(6):767-78
pubmed: 8651649
Cold Spring Harb Perspect Biol. 2018 May 1;10(5):
pubmed: 28778873
Neurology. 2000 Oct 10;55(7):1055-7
pubmed: 11061272
J Clin Neurosci. 2000 May;7(3):203-8
pubmed: 10833616
Brain. 2006 Sep;129(Pt 9):2297-317
pubmed: 16923955
Brain. 2011 Jun;134(Pt 6):1829-38
pubmed: 21616973
Neuropathol Appl Neurobiol. 1998 Apr;24(2):125-30
pubmed: 9634208
Nucleic Acids Res. 2020 Nov 4;48(19):10615-10631
pubmed: 32776089
Biochem J. 2006 Nov 1;399(3):435-44
pubmed: 16824036
J Virol. 1987 Dec;61(12):3688-93
pubmed: 2446004
Acta Neuropathol. 2009 Nov;118(5):659-71
pubmed: 19718500
Brain. 2009 Oct;132(Pt 10):2643-58
pubmed: 19734292
Brain. 2009 Oct;132(Pt 10):2659-68
pubmed: 19773352
Cell. 1984 Aug;38(1):127-34
pubmed: 6432339
Neurology. 2020 Jan 14;94(2):e153-e157
pubmed: 31757870
Protein Sci. 2006 Mar;15(3):609-19
pubmed: 16452616
Hum Mutat. 2010 Jul;31(7):E1551-63
pubmed: 20583301
Pract Neurol. 2019 Feb;19(1):49-55
pubmed: 30282760
Brain. 2006 Sep;129(Pt 9):2266-77
pubmed: 16923954
Neurology. 2012 Aug 7;79(6):547-52
pubmed: 22843257
J Neurol Neurosurg Psychiatry. 2008 Dec;79(12):1395-8
pubmed: 19010951
Neurobiol Aging. 2018 Nov;71:265.e1-265.e7
pubmed: 29861043
Brain. 2003 Jun;126(Pt 6):1333-46
pubmed: 12764055
Methods Mol Biol. 2017;1658:311-346
pubmed: 28861799
EMBO J. 1996 Mar 15;15(6):1255-64
pubmed: 8635458
J Neurol Neurosurg Psychiatry. 2004 Aug;75(8):1166-70
pubmed: 15258222
Lancet Neurol. 2020 Oct;19(10):840-848
pubmed: 32949544
Acta Neuropathol Commun. 2013 May 09;1:8
pubmed: 24252267
Proc Natl Acad Sci U S A. 1991 Dec 1;88(23):10926-30
pubmed: 1683708

Auteurs

Nicholas Brennecke (N)

Department of Neurology, Case Western Reserve University & University Hospitals Cleveland Medical, Cleveland, OH 44106, USA.

Ignazio Cali (I)

Department of Pathology, School of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA.
National Prion Disease Pathology Surveillance Center (NPDPSC), Cleveland, OH 44106, USA.

Tze How Mok (TH)

MRC Prion Unit at University College London, Institute of Prion Diseases, London W1W 7FF, UK.

Helen Speedy (H)

MRC Prion Unit at University College London, Institute of Prion Diseases, London W1W 7FF, UK.
Genomics England Limited of Dawson Hall, Charterhouse Square, London EC1M 6BQ, UK.

Laszlo L P Hosszu (LLP)

MRC Prion Unit at University College London, Institute of Prion Diseases, London W1W 7FF, UK.

Christiane Stehmann (C)

Australian National Creutzfeldt-Jakob Disease Registry, The Florey Institute, The University of Melbourne, Melbourne, VIC 3010, Australia.

Laura Cracco (L)

Department of Pathology and Laboratory Medicine, School of Medicine, Indiana University, Indianapolis, IN 46202, USA.

Gianfranco Puoti (G)

Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", 81100 Caserta, Italy.
Prion Disease Diagnosis and Surveillance Center (PDDSC), University of Campania "Luigi Vanvitelli", 81100 Caserta, Italy.

Thomas W Prior (TW)

Center for Human Genetics Laboratory, Case Western Reserve University & University Hospitals Cleveland Medical Center, Cleveland, OH 44106, USA.

Mark L Cohen (ML)

Department of Neurology, Case Western Reserve University & University Hospitals Cleveland Medical, Cleveland, OH 44106, USA.
Department of Pathology, School of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA.
National Prion Disease Pathology Surveillance Center (NPDPSC), Cleveland, OH 44106, USA.

Steven J Collins (SJ)

Australian National Creutzfeldt-Jakob Disease Registry, The Florey Institute, The University of Melbourne, Melbourne, VIC 3010, Australia.

Simon Mead (S)

MRC Prion Unit at University College London, Institute of Prion Diseases, London W1W 7FF, UK.

Brian S Appleby (BS)

Department of Neurology, Case Western Reserve University & University Hospitals Cleveland Medical, Cleveland, OH 44106, USA.
Department of Pathology, School of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA.
National Prion Disease Pathology Surveillance Center (NPDPSC), Cleveland, OH 44106, USA.
Department of Psychiatry, Case Western Reserve University & University Hospitals, Cleveland, OH 44106, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH